These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35098933)

  • 1. Cellular senescence in the cholangiopathies.
    Bogert PS; O'Hara SP; LaRusso NF
    Curr Opin Gastroenterol; 2022 Mar; 38(2):121-127. PubMed ID: 35098933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
    Trussoni CE; O'Hara SP; LaRusso NF
    Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis.
    Tabibian JH; O'Hara SP; Splinter PL; Trussoni CE; LaRusso NF
    Hepatology; 2014 Jun; 59(6):2263-75. PubMed ID: 24390753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the
    Alsuraih M; O'Hara SP; Woodrum JE; Pirius NE; LaRusso NF
    JHEP Rep; 2021 Jun; 3(3):100250. PubMed ID: 33870156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2
    Zhou T; Kyritsi K; Wu N; Francis H; Yang Z; Chen L; O'Brien A; Kennedy L; Ceci L; Meadows V; Kusumanchi P; Wu C; Baiocchi L; Skill NJ; Saxena R; Sybenga A; Xie L; Liangpunsakul S; Meng F; Alpini G; Glaser S
    EBioMedicine; 2019 Oct; 48():130-142. PubMed ID: 31522982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
    Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
    J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy and senescence in fibrosing cholangiopathies.
    Nakanuma Y; Sasaki M; Harada K
    J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages in cholangiopathies.
    Bruneau A; Guillot A; Tacke F
    Curr Opin Gastroenterol; 2022 Mar; 38(2):114-120. PubMed ID: 35098932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor.
    Al Suraih MS; Trussoni CE; Splinter PL; LaRusso NF; O'Hara SP
    Liver Int; 2020 Oct; 40(10):2455-2468. PubMed ID: 32558183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis.
    Tabibian JH; Trussoni CE; O'Hara SP; Splinter PL; Heimbach JK; LaRusso NF
    Lab Invest; 2014 Oct; 94(10):1126-33. PubMed ID: 25046437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.
    Loarca L; De Assuncao TM; Jalan-Sakrikar N; Bronk S; Krishnan A; Huang B; Morton L; Trussoni C; Bonilla LM; Krueger E; O'Hara S; Splinter P; Shi G; Pisarello MJL; Gores GJ; Huebert RC; LaRusso NF
    Lab Invest; 2017 Nov; 97(11):1385-1396. PubMed ID: 28892096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Acids and Biliary Fibrosis.
    Aseem SO; Hylemon PB; Zhou H
    Cells; 2023 Mar; 12(5):. PubMed ID: 36899928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.
    Grama A; Mititelu A; Sîrbe C; Benţa G; Pop TL
    Front Immunol; 2023; 14():1206025. PubMed ID: 37928553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis.
    Guicciardi ME; Trussoni CE; LaRusso NF; Gores GJ
    Hepatology; 2020 Feb; 71(2):741-748. PubMed ID: 31833071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
    Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
    Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis.
    Cazzagon N; Sarcognato S; Floreani A; Corrà G; De Martin S; Guzzardo V; Russo FP; Guido M
    JHEP Rep; 2021 Jun; 3(3):100286. PubMed ID: 34041468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes.
    Wan Y; Ceci L; Wu N; Zhou T; Chen L; Venter J; Francis H; Bernuzzi F; Invernizzi P; Kyritsi K; Baker P; Huang Q; Wu C; Sybenga A; Alpini G; Meng F; Glaser S
    Lab Invest; 2019 Jun; 99(6):764-776. PubMed ID: 30700848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-induced cellular responses and cell death mechanisms during inflammatory cholangiopathies.
    Sasaki M; Nakanuma Y
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):129-138. PubMed ID: 27618480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere dysfunction promotes cholangiocyte senescence and biliary fibrosis in primary sclerosing cholangitis.
    Jalan-Sakrikar N; Anwar A; Yaqoob U; Gan C; Lagnado AB; Wixom AQ; Jurk D; Huebert RC
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37707950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.